Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-25 4:20 pm Purchase |
2021-01-20 | 13G | Allena Pharmaceuticals, Inc. ALNAQ |
HIRSCHMAN ORIN | 4,000,000 8.000% |
4,000,000 (New Position) |
Filing History |
| 2021-01-20 07:20 am Purchase |
2021-01-14 | 13G | Evoke Pharma, Inc. EVOK |
HIRSCHMAN ORIN | 11,806 5.300% |
11,806 (New Position) |
Filing History |
| 2021-01-19 10:01 am Purchase |
2021-01-15 | 13G | Yield10 Bioscience, Inc. YTEN |
HIRSCHMAN ORIN | 12,500 9.000% |
12,500 (New Position) |
Filing History |
| 2021-01-12 06:42 am Purchase |
2020-12-31 | 13G | Franklin Wireless Corp. FKWL |
HIRSCHMAN ORIN | 780,000 6.800% |
780,000 (New Position) |
Filing History |
| 2020-12-28 4:57 pm Sale |
2020-12-23 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
HIRSCHMAN ORIN | 1,173 4.000% |
-827 (-41.34%) |
Filing History |
| 2020-12-28 06:11 am Purchase |
2020-12-17 | 13G | LightPath Technologies, Inc. LPTH |
HIRSCHMAN ORIN | 1,834,131 7.000% |
1,834,131 (New Position) |
Filing History |
| 2020-12-28 06:10 am Purchase |
2020-12-17 | 13G | EMCORE Corporation EMKR |
HIRSCHMAN ORIN | 197,901 6.700% |
197,901 (New Position) |
Filing History |
| 2020-12-17 08:11 am Purchase |
2020-12-08 | 13G | Cyclo Therapeutics, Inc. CYTH |
HIRSCHMAN ORIN | 418,000 9.900% |
418,000 (New Position) |
Filing History |
| 2020-12-14 07:15 am Sale |
2020-12-11 | 13G | SELLAS Life Sciences Group, Inc. SLS |
HIRSCHMAN ORIN | 190,000 1.500% |
-746,735 (-79.72%) |
Filing History |
| 2020-12-09 06:49 am Purchase |
2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
HIRSCHMAN ORIN | 2,000 6.900% |
2,000 (New Position) |
Filing History |
| 2020-12-04 06:16 am Purchase |
2020-11-23 | 13G | Myomo, Inc. MYO |
HIRSCHMAN ORIN | 416,059 9.100% |
416,059 (New Position) |
Filing History |
| 2020-11-27 2:30 pm Purchase |
2020-11-17 | 13G | Aptevo Therapeutics Inc. APVO |
HIRSCHMAN ORIN | 75 2.950% |
75 (New Position) |
Filing History |
| 2020-11-19 06:44 am Sale |
2020-11-11 | 13G | Everspin Technologies, Inc. MRAM |
HIRSCHMAN ORIN | 354,897 11.000% |
-595,103 (-62.64%) |
Filing History |
| 2020-11-06 07:25 am Purchase |
2020-11-04 | 13G | O2Micro International Limited OIIM |
HIRSCHMAN ORIN | 1,828,199 6.800% |
1,828,199 (New Position) |
Filing History |
| 2020-09-17 07:43 am Sale |
2020-09-08 | 13G | TETRA Technologies, Inc. TTI |
HIRSCHMAN ORIN | 3,563,342 2.830% |
-3,194,387 (-47.27%) |
Filing History |
| 2020-08-25 09:02 am Purchase |
2020-08-03 | 13G | SELLAS Life Sciences Group, Inc. SLS |
HIRSCHMAN ORIN | 936,735 9.900% |
936,735 (New Position) |
Filing History |
| 2020-08-06 11:43 am Purchase |
2020-07-22 | 13G | Acer Therapeutics Inc. ACER |
HIRSCHMAN ORIN | 982,446 11.000% |
430,406 (+77.97%) |
Filing History |
| 2020-07-21 5:17 pm Purchase |
2020-07-21 | 13G | TETRA Technologies, Inc. TTI |
HIRSCHMAN ORIN | 6,757,729 5.370% |
6,757,729 (New Position) |
Filing History |
| 2020-07-21 08:03 am Purchase |
2020-07-10 | 13G | Annovis Bio, Inc. ANVS |
HIRSCHMAN ORIN | 498,797 7.270% |
175,507 (+54.29%) |
Filing History |
| 2020-07-10 4:20 pm Sale |
2020-07-07 | 13G | Annovis Bio, Inc. ANVS |
HIRSCHMAN ORIN | 323,290 4.740% |
-191,710 (-37.23%) |
Filing History |